You're viewing a free preview.You're viewing a free preview — a sample of each dataset.
News Feed
Curated longevity industry headlines with AI summaries, updated continuously.
452 news items tracked
| Headline | Published |
|---|---|
| eGenesis reports encouraging Expanded Access results for engineered pig kidney, FDA-cleared pivotal trial ahead | 09/03/26 |
| Pig kidney xenotransplant successfully bridges patient to human transplant, Lancet reports | 09/03/26 |
| Biogen and Eisai win China approval for at-home subcutaneous LEQEMBI in early Alzheimer's | 09/03/26 |
| FibroBiologics wins new patent for fibroblast spheroid wound-healing therapy | 09/03/26 |
| Insilico Medicine added to HKEX Tech 100 Index | 09/02/26 |
| Rapalogix Health opens research lab at Princeton BioLabs to study rapalog compounds in skin biology | 09/02/26 |
| HCW Biologics secures new patent for HCW9302, reports encouraging early alopecia areata trial signal | 09/02/26 |
| Scribe Therapeutics reports Q2 results: first-in-human CRISPR trial dosed, $155M IPO closed | 09/02/26 |
| Mito Health hits 1M lab tests processed as it broadens beyond its original longevity-panel focus | 09/02/26 |
| Yuva Biosciences and Northstrive expand AI drug discovery partnership toward lead compound nomination | 09/01/26 |
Showing 10 of 452 news items
7-day free trial · already have an account?
Peek at other modules
Companies
The longevity company universe by segment, stage, geography and capital raised.
Funding Tracker
Every disclosed longevity round — size, stage and the investors behind it.
Clinical Trials
Longevity-relevant trials by phase, sponsor, status and indication.
People & Movers
Who is joining, leaving and founding across the longevity sector.
Research
Peer-reviewed aging research distilled into investor-relevant takeaways.
Regulatory
FDA, EMA and policy developments that move the longevity market.